Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin to prevent aminoglycoside-induced kidney toxicity in children with cystic fibrosis
2014-002387-32Phase 2Completed
- Sponsor
- University of Liverpool
- Start
- Jun 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of rosuvastatin in cystic fibrosis (CF) and nephrotoxicity (2 arms), sponsored by University of Liverpool. Started Jun 2014; status: completed.
02
Drugs
rosuvastatin
03
Conditions
cystic fibrosis (CF)nephrotoxicity
Beyond the preview
Go deeper on 2014-002387-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002387-32.